Aptahem Launches US Stock Market Listing Process to Fund Clinical Trials
Aptahem begins the process of listing on a US stock exchange to secure funding for clinical trials.
Aptahem begins the process of listing on a US stock exchange to secure funding for clinical trials.
Aptahem begins the process of listing on a US stock exchange to secure funding for clinical trials.